Studies on the Anti-Inflammatory Effect of Xiaoyao Pills in The Treatment of Postmenopausal Osteoporosis in Mice
August 23rd, 2024
Postmenopausal osteoporosis has become a global public health problem. The aim of this study is to explore the therapeutic effects and related mechanisms of the traditional Chinese medicine Xiaoyao pills on this condition.
The scope of this study was the therapeutic effect of the Chinese medicine xiaoyao pills on mice with postmenopausal osteoporosis. In this study, we wanted to confirm whether the xiaoyao pills could exert a therapeutic effect and the specific mechanism. In this study, we combine the traditional Chinese medicine with modern pharmacology and the normal genus and authorized by informations to search and medically analyze the protein dose event will show your cure.
Also process compared with single pharmacology our genome just analyze our scheme is more comprehensive and may provide new idea for the treatments of osteoporosis. This idea will promote the development of the field of traditional Chinese medicine for osteoporosis, promote and advance understanding of the mechanism and revolution of traditional Chinese medicine, its primary research idea, and the direction of the provider practical guidance and efficacious evaluation visit of our clinical application. To begin disease associated gene merging, place the previously saved text files from five databases containing the herbal name, ingredient ID, gene ID, and the script disease dot R in the same folder.
Open the R code. Copy and paste the path where the text file is stored into the line where the set WD is located in the R code. Open the R software.
Run the modified R code and save. Set the gene and name the file disease dot text. Open the Venn diagram website.
In the input section, copy and paste the already-saved text content into the list. Name the content with the respective database and click submit. Click save images PNG below the image and save the text result in the same folder.
Place the all targets dot symbol dot text file and the disease dot text file in the same folder. Open the R code. Copy and paste the path where the text file is stored into the line where the set WD is located in the R code.
Open the R software, run the modified R code and save. Set the gene and name the file drug disease dot text. Open the Venn diagram website.
In the input section, copy and paste all targets dot symbol dot text and disease dot text into the list and name the files. Click save image as PNG below the image and save the text results in the same folder. Open the String website and click multiple protein.
Click browse and upload the drug disease dot text file. Then select Homo sapiens in organisms. Click search, followed by continue.
Now click settings and set the minimum required interaction score to the highest confidence. From the network display option, check hide disconnected nodes in the network. Then click update.
Adjust the nodes in the network diagram so that there is no overlap or occlusion. Click exports, followed by download as a high resolution bitmap to get the protein inter-working network map in PNG format. Download the TSV file as a short tabular text output.
Save PNG and TSV files in a unified folder. To begin prepare wax blocks from euthanized mice injected with xiaoyao pills. Cut the wax blocks into six micrometer thick continuous sections and bake the slices at 70 to 72 degrees Celsius for 30 to 60 minutes.
Transfer the slices to the dewaxing solution for eight minutes, then dehydrate twice in 75%anhydrous ethanol for five minutes each before rinsing in PBS for five minutes. Now perform EDTA high pressure repair for 15 minutes. After rinsing with PBS, drop-wise, add 3%hydrogen peroxide to the tissue and incubate for 10 minutes.
Wash the tissue three times with PBS for five minutes each. Using an immunohistochemistry pen, draw a circle around the tissue. After washing the tissue with PBS, stain overnight in primary antibody solution.
The following day, rinse the tissue three times for five minutes each in PBS. Drop-wise, add the secondary antibody and incubate for 60 minutes. After rinsing with PBS, incubate the tissue in DAB ready to use solution for three to five minutes.
Now stain the tissue in hematoxylin for three minutes. Again, rinse the tissue with PBS before placing it in differentiation solution for 10 seconds. After PBS rinse, add the return solution for 10 seconds.
Finally, perform 75%anhydrous ethanol treatment for five minutes and seal the slide with neutral resin. Hematoxylin eosin staining showed tightly arranged trabeculae in sham mice, while OVX mice displayed typical osteoporotic changes, with sparse trabeculae and enlarged marrow cavities. Micro-CT comparison showed incomplete trabecular meshwork and thinning of the bone cortex in OVX mice compared to sham mice.
After drug intervention, hematoxylin eosin staining showed restored trabeculae structure and reduced marrow cavity compared to the OVX group. Imaging indices showed fewer fractured trabeculae and restored reticulation in the high dose xiaoyao pills group compared to the OVX group. Immunohistochemistry results showed increased alkaline phosphatase and collagen type one and decreased interleukin-17, ACT one and interleukin-6 in the drug group.
Overview
This study investigates the therapeutic effects of traditional Chinese medicine Xiaoyao pills on postmenopausal osteoporosis in mice. It combines traditional practices with modern pharmacological methods to evaluate the pills' efficacy and mechanisms of action.
Key Study Components
Research Area
- Postmenopausal osteoporosis
- Traditional Chinese medicine
- Therapeutic mechanisms
Background
- Rising global incidence of postmenopausal osteoporosis
- Need for effective treatments
- Integration of traditional and modern pharmacological approaches
Methods Used
- Use of Xiaoyao pills in a mouse model
- Histological analysis and staining techniques
- Immunohistochemistry for biomarker evaluation
Main Results
- Xiaoyao pills improved trabecular structure in mice
- Restored bone density and reduced marrow cavity size
- Altered levels of key biomarkers associated with bone health
Conclusions
- The study demonstrates potential for Xiaoyao pills as a treatment for osteoporosis
- This research advances understanding of traditional Chinese medicine and its applications in modern health challenges
Frequently Asked Questions
Executive Industry Relevance
Integrating traditional Chinese medicine with modern pharmacological network analysis, this study interrogates the anti-inflammatory and bone-protective mechanisms of Xiaoyao pills in a postmenopausal osteoporosis mouse model. The approach leverages multi-database target mapping and protein interaction networks to clarify pathway involvement, supporting mechanistic de-risking and target validation in early discovery. These findings inform translational strategies for novel osteoporosis therapeutics and highlight the value of systems pharmacology in portfolio triage.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Network pharmacology and multi-database gene mapping clarify therapeutic hypothesis and pathway engagement.
- Protein interaction analysis via STRING and Cytoscape supports functional target validation and mechanistic de-risking.
- Integration of traditional and modern data sources enhances predictive confidence for candidate selection.
Screening & Assay Development
- Immunohistochemistry and biomarker quantification enable standardized assessment of bone tissue response.
- Quantitative readouts for ALP, COL-1, and inflammatory cytokines support reproducibility and assay readiness.
- Histological and imaging indices provide robust endpoints for compound evaluation in preclinical models.
Translational & Preclinical Research
- Ovariectomized mouse model ensures disease relevance for postmenopausal osteoporosis studies.
- Alignment of biomarker changes with clinical endpoints supports translational continuity.
- IL-17 pathway modulation offers mechanistic insight for risk-adjusted advancement decisions.
Pipeline & Workflow Integration
This workflow spans early discovery through preclinical validation, integrating target identification, pathway analysis, and in vivo efficacy assessment.
- Discovery Biology: Multi-database gene and protein mapping supports hypothesis testing and pathway clarification.
- Screening: Quantitative immunohistochemistry and imaging enable reproducible, scalable readouts.
- Analytics: Statistical comparison of biomarker levels and imaging indices informs condition-specific effects.
- Translational Research: Disease-relevant animal models and biomarker alignment facilitate preclinical continuity.
- Enterprise Reuse: The integrated network pharmacology and in vivo workflow is adaptable for other complex disease models.
Operational & Enterprise Impact
- Scientific Value: Enhanced predictive confidence and mechanistic clarity for anti-osteoporotic interventions.
- Operational Value: Standardized, reproducible protocols for biomarker and imaging analysis.
- Strategic Value: Informed go/no-go decisions and reduced late-stage biological risk through pathway de-risking.
- Portfolio Impact: Supports risk-adjusted prioritization of novel therapeutic candidates for osteoporosis.
Implementation Considerations
- Requires expertise in network pharmacology, bioinformatics, and in vivo bone disease models.
- Demands access to multi-database resources, R software, and imaging infrastructure.
- Cross-team standardization is essential for reproducible biomarker and imaging outputs.
- Adaptation to other disease models may require pathway-specific validation.
- Limitations include reliance on animal models and the need for further translational validation.
